HR 7213, the *Safeguarding Benefits for Americans Act of 2026*, requires U.S. citizenship or nationality for eligibility for most federal assistance programs (like SNAP, housing aid, or Medicaid). It mandates applicants to submit a written declaration under penalty of perjury and provide documentary proof (e.g., birth certificate, SSN) verified through Social Security Administration and DHS databases. The bill affects individuals applying for or receiving federal benefits, with exceptions for children in households where at least one member meets the requirement (e.g., children in SNAP or elderly housing programs). It takes effect 1 year after enactment, requiring all current recipients to meet the new rules within 2 years.
This bill extends and modifies the premium tax credit (subsidy) for health insurance purchased through the marketplace, applying to coverage for 2026 and 2027. It raises the income threshold for full subsidy eligibility from 400% to 600% of the federal poverty level, meaning more low-to-moderate-income households (up to 600% of poverty) will pay lower monthly insurance costs. The bill also adds new penalties for agents or brokers who provide false information during enrollment, including civil fines up to $50,000 per person and criminal charges for intentional fraud. These changes directly affect individuals buying health insurance through marketplaces and the agents/brokers who assist them.
S 180, the Protecting First Responders from Secondary Exposure Act of 2025, requires the federal government to provide training and resources for first responders on using containment devices to prevent accidental exposure to fentanyl and other dangerous substances. It mandates the purchase of these containment devices for first responder use. The bill amends existing law (34 U.S.C. 10701(a)) by adding a new provision (paragraph (4)) that specifically addresses this safety measure. This directly affects police, firefighters, and emergency medical personnel who may encounter fentanyl during their duties. The key mechanism is the federal funding and requirement for both training and procurement of protective equipment.
HR 6757, the Relief for Survivors of Miners Act of 2025, simplifies the process for survivors to receive black lung benefits by changing how deaths from pneumoconiosis (black lung disease) are proven. It creates a rebuttable presumption that a miner’s death was caused by black lung if they worked 10+ years in coal mines or were totally disabled by the disease before death, making it harder for claims to be denied. The bill also establishes a program to pay up to $4,500 in attorneys’ fees and $3,000 in medical expenses for qualifying claims through a federal fund, with operators later reimbursing the fund if benefits are approved. Additionally, it requires the Government Accountability Office to review interim payments, benefit adequacy, and potential policy changes for black lung survivors.
HR 5031, the *Preserving Patient Access to Long-Term Care Pharmacies Act*, requires Medicare Part D plans and Medicare Advantage plans with drug coverage (MA-PD) to pay long-term care pharmacies an additional supply fee for each specified prescription dispensed to eligible beneficiaries during 2026 ($30) and 2027 (adjusted for inflation). This fee must be paid alongside existing reimbursements for drug costs and dispensing, with a $10,000 penalty for non-payment. The bill also directs the GAO to study long-term care pharmacy payment sustainability under Medicare, analyzing historical payments for brand/generic drugs and dispensing fees. It aims to ensure uninterrupted pharmacy access for Medicare beneficiaries in long-term care settings, particularly in rural areas.
This bill creates a 50% tax credit for qualified infertility treatments, allowing eligible individuals to reduce their federal income tax by half their eligible expenses. It directly affects people diagnosed with infertility or those needing fertility preservation (e.g., before cancer treatment) who pay for physician-provided care. The credit is capped at $5,000 annually (adjusted for inflation), phases out for taxpayers with adjusted gross income over $40,000, and cannot be claimed if expenses are covered by insurance or other programs. The credit applies to tax years beginning after December 31, 2024.
This bill requires the Department of Veterans Affairs (VA) to proactively reschedule mental health appointments for enrolled veterans who cancel them. Specifically, if a veteran cancels a mental health appointment (defined as a veteran enrolled in the VA's standard patient system under 38 U.S.C. §1705(a)), the VA must contact them by phone at least twice to reschedule - first immediately, and then if not rescheduled on the first call. The key mechanism is mandating two telephone attempts to reconnect veterans who cancel, aiming to prevent gaps in care. This directly affects veterans using VA mental health services who cancel appointments, ensuring they receive follow-up support.
HR 272, the Protecting Life and Taxpayers Act of 2025, prohibits federal funding (directly or indirectly) to any organization that performs or funds abortions, requiring certification from all recipients. This applies to entities receiving federal funds, including contractors and subsidiaries, with limited exceptions for pregnancies resulting from rape or incest, or when a physician certifies a life-threatening condition. The bill directly affects healthcare providers, clinics, and organizations that rely on federal grants or contracts. It changes existing funding rules by banning federal money from supporting abortion services, except in the specified medical or criminal exceptions.
This bill requires the Federal Trade Commission (FTC) to study how pharmacy benefit managers (PBMs) and other intermediaries affect prescription drug prices and competition. Specifically, the FTC must report within one year on whether PBMs charge different prices to pharmacies, steer patients toward pharmacies they own, use pharmacy data for profit, or design formularies to favor expensive drugs. The bill also mandates an interim report within six months and a separate study on sole-source drug manufacturers and enforcement challenges. It does not directly change drug prices or create new regulations, but instead seeks to gather data to inform potential future policy actions. The study focuses on transparency and competition in the pharmaceutical supply chain, with no immediate price-reducing mechanisms.
This bill provides federal grants to public or nonprofit health care providers serving minority, low-income, or medically underserved communities to expand maternal and infant health services. It specifically funds prenatal, postnatal, and postpartum care while requiring grantees to offer culturally appropriate services and limit administrative costs to 10% of grant funds. Priority is given to organizations led by or located within the communities they serve, aiming to reduce racial and economic disparities in care access and health outcomes. The funding is authorized for fiscal years 2026-2030, with grantees required to coordinate with other federal maternal health programs to avoid duplication.
